Tumor-initiating activity and tumor morphology of HNSCC is modulated by interactions between clonal variants within the tumor

Laboratory Investigation

Volumn 90, Issue 11, 2010, Pages 1594-1603

  Cameron, Sarina R ^a   Dahler, Alison L ^a   Endo Munoz, Liliana B ^a   Jabbar, Ibtissam ^a   Thomas, Gethin P ^a   Leo, Paul J ^a   Poth, Kim ^a   Rickwood, Danny ^a   Guminski, Alexander ^a   Saunders, Nicholas A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

keratinocytes; squamous cell carcinoma; tumor initiation

Indexed keywords

CD133 ANTIGEN; HERMES ANTIGEN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER STEM CELL; CARCINOGENICITY; CELL INTERACTION; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL LINE, TUMOR; GLYCOPROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, SCID; PEPTIDES;

EID: 78049339202     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.131     Document Type: Article

References (46)

1. Prince ME, Ailles LE. Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol 2008;26:2871-2875.
2. Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008;83:489-501.
3. Campbell LL, Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 2007;6:2332-2338. (Pubitemid 350058682)
4. Wang JC, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005;15:494-501.
5. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-28.
6. Kelly PN, Dakic A, Adams JM, et al. Tumor growth need not be driven by rare cancer stem cells. Science 2007;317:337.
7. Quintana E, Shackleton M, Sabel MS, et al. Efficient tumor formation by single human melanoma cells. Nature 2008;456:593-598.
8. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994;367:645-648.
9. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-3988. (Pubitemid 36418143)
10. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumor initiating cells. Nature 2004;432:396-401.
11. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007; 104:973-978.
12. Hill RP. Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 2006;66:1891-1895; discussion 1890.
13. Kern SE, Shibata D. The fuzzy math of solid tumor stem cells: a perspective. Cancer Res 2007;67:8985-8988.
14. Mishra PJ, Humeniuk R, Medina DJ, et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008;68:4331-4339.
15. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angio-genesis through elevated SDF-1/CXCL12 secretion. Cell 2005;121:335-348.
16. Kuperwasser C, Chavarria T, Wu M, et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004;101:4966-4971.
17. Shankaran V, Ikeda H, Bruce AT, et al. IFNgamma and lymphocytes prevent primary tumor development and shape tumor immunogenicity. Nature 2001;410:1107-1111.
18. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004;22:329-360.
19. Swann JB, Vesely MD, Silva A, et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc Natl Acad Sci USA 2008;105:652-656.
20. Ulrich C, Schmook T, Sachse MM, et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004;30(4 Part 2):622-627.
21. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6:17-32. (Pubitemid 38903159)
22. Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumor stroma promote breast cancer metastasis. Nature 2007;449:557-563.
23. Coffelt SB, Hughes R, Lewis CE. Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 2009;1796:11-18.
24. Qiu W, Hu M, Sridhar A, et al. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 2008;40:650-655.
25. Redvers RP, Li A, Kaur P. Side population in adult murine epidermis exhibits phenotypic and functional characteristics of keratinocyte stem cells. Proc Natl Acad Sci USA 2006;103:13168-13173.
26. Harper LJ, Piper K, Common J, et al. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. J Oral Pathol Med 2007;36:594-603.
27. Gu W, Putral L, Hengst K, et al. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Ther 2006;13:1023-1032.
28. Dahler AL, Rickwood D, Guminski A, et al. Indole-3-carbinol-induced growth inhibition can be converted to a cytotoxic response in the presence of TPA+Ca(2+) in squamous cell carcinoma cell lines. FEBS Lett 2007;581:3839-3847.
29. Duan R, Leo P, Bradbury L, et al. Gene expression profiling reveals a down-regulation in immune-associated genes in AS patients. Ann Rheum Dis; published online 29 July 2009 (e-pub ahead of print).
30. Patrawala L, Calhoun T, Schneider-Broussard R, et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006;25:1696-1708.
31. Shepherd CJ, Rizzo S, Ledaki I, et al. Expression profiling of CD133(+) and CD133(-) epithelial cells from human prostate. Prostate 2008;68:1007-1024.
32. Terunuma A, Kapoor V, Yee C, et al. Stem cell activity of human side population and alpha6 integrin-bright keratinocytes defined by a quantitative in vivo assay. Stem Cells 2007;25:664-669.
33. Mackenzie IC, Bickenbach JR. Label-retaining keratinocytes and Langerhans cells in mouse epithelia. Cell Tissue Res 1985;242:55 1-556.
34. Moshaver B, van Rhenen A, Kelder A, et al. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia. Stem Cells 2008;26:3059-3067.
35. Holyoake T, Jiang X, Eaves C, et al. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 1999;94:2056-2064.
36. Kabashima A, Higuchi H, Takaishi H,etal. Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion. Int J Cancer 2009;124:2771-2779.
37. Zhang HB, Ren CP, Yang XY, et al. Identification of label-retaining cells in nasopharyngeal epithelia and nasopharyngeal carcinoma tissues. Histochem Cell Biol 2007;127:347-354.
38. Gascoigne KE, Taylor SS. Cancer cells display profound intra-and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 2008;14:111-122.
39. Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tumor dormancy. APMIS 2008;116:754-770.
40. Funke I, Schraut W. Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 1998;16:557-566.
41. Quesnel B. Tumor dormancy and immunoescape. APMIS 2008;116:685-694.
42. Achilles EG, Fernandez A, Allred EN, et al. Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for 'no take' of human tumors in mice. J Natl Cancer Inst 2001;93:1075-1081.
43. Udagawa T. Tumor dormancy of primary and secondary cancers. APMIS 2008;116:615-628.
44. Revesz L. Effect of tumor cells killed by X-rays upon the growth of admixed viable cells. Nature 1956;178:1391-1392.
45. Grimm D, Bauer J, Schoenberger J. Blockade of neoangiogenesis, a new and promising technique to control the growth of malignant tumors and their metastases. Curr Vasc Pharmacol 2009;7:347-357.
46. Hu M, Yao J, Carroll DK, et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008;13:394-406.